Investment Case

Differential business model

• Acquire, prepare, commercialise

Global Commerical Deal

• Global commercial deal for the launch of unique skincare brand Skin + CELL announced Dec 2023, expected to generate significant revenues and profitability in 2024 and beyond

Strategic partners (second commercial deal signed)

• Proves business model to commercialise products at earliest stage

Multi-product portfolio

• Minimises risk of single product development

Newsflow

• Driving shareholder value